ATC Group: B05CA05 Taurolidine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of B05CA05 in the ATC hierarchy

Level Code Title
1 B Blood and blood forming organs
2 B05 Blood substitutes and perfusion solutions
3 B05C Irrigating solutions
4 B05CA Antiinfectives
5 B05CA05 Taurolidine

Active ingredients in B05CA05

Active Ingredient Description
Taurolidine

Taurolidine inhibits the formation of postoperative peritoneal adhesions, and in vitro has been shown to reduce the adherence of micro-organisms to mucosal epithelium. The chemical mode of action of taurolidine via its reactive methylol groups confers greater potency in vivo than indicated by in vitro MIC values, and also appears to preclude susceptibility to resistance mechanisms.

Related product monographs

Title Information Source Document Type  
TAUROLIN Solution for intraperitoneal lavage after dilution or solution for instillation Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Ireland (IE)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.